CN106720829A - A kind of polygonatum Solomon's seal sugar-tablet and preparation method thereof - Google Patents
A kind of polygonatum Solomon's seal sugar-tablet and preparation method thereof Download PDFInfo
- Publication number
- CN106720829A CN106720829A CN201611079468.XA CN201611079468A CN106720829A CN 106720829 A CN106720829 A CN 106720829A CN 201611079468 A CN201611079468 A CN 201611079468A CN 106720829 A CN106720829 A CN 106720829A
- Authority
- CN
- China
- Prior art keywords
- parts
- weight
- tablet
- sugar
- seal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000756042 Polygonatum Species 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims abstract description 20
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 14
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 12
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 12
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims abstract description 10
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 10
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims abstract description 10
- 235000010234 sodium benzoate Nutrition 0.000 claims abstract description 10
- 239000004299 sodium benzoate Substances 0.000 claims abstract description 10
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 9
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 9
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 239000000203 mixture Substances 0.000 claims description 12
- 239000002245 particle Substances 0.000 claims description 11
- 239000000047 product Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 238000007654 immersion Methods 0.000 claims description 7
- 239000000853 adhesive Substances 0.000 claims description 6
- 230000001070 adhesive effect Effects 0.000 claims description 6
- 239000003651 drinking water Substances 0.000 claims description 6
- 235000020188 drinking water Nutrition 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 239000004033 plastic Substances 0.000 claims description 4
- 229920003023 plastic Polymers 0.000 claims description 4
- 238000003860 storage Methods 0.000 claims description 4
- 238000003556 assay Methods 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000008188 pellet Substances 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- 239000010935 stainless steel Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 20
- 210000004369 blood Anatomy 0.000 abstract description 9
- 239000008280 blood Substances 0.000 abstract description 9
- 238000010521 absorption reaction Methods 0.000 abstract description 8
- 230000006870 function Effects 0.000 abstract description 8
- 230000002218 hypoglycaemic effect Effects 0.000 abstract description 7
- 230000036039 immunity Effects 0.000 abstract description 7
- 208000034189 Sclerosis Diseases 0.000 abstract description 6
- 210000001367 artery Anatomy 0.000 abstract description 6
- 150000002632 lipids Chemical class 0.000 abstract description 6
- 230000002708 enhancing effect Effects 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 210000004185 liver Anatomy 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 235000008737 Polygonatum biflorum Nutrition 0.000 description 4
- 241000037831 Polygonatum sibiricum Species 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 235000001465 calcium Nutrition 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 229920001202 Inulin Polymers 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 239000007928 intraperitoneal injection Substances 0.000 description 3
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 3
- 229940029339 inulin Drugs 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 150000004804 polysaccharides Chemical class 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000255789 Bombyx mori Species 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 244000241872 Lycium chinense Species 0.000 description 2
- 235000015468 Lycium chinense Nutrition 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- LYPFDBRUNKHDGX-SOGSVHMOSA-N N1C2=CC=C1\C(=C1\C=CC(=N1)\C(=C1\C=C/C(/N1)=C(/C1=N/C(/CC1)=C2/C1=CC(O)=CC=C1)C1=CC(O)=CC=C1)\C1=CC(O)=CC=C1)C1=CC(O)=CC=C1 Chemical compound N1C2=CC=C1\C(=C1\C=CC(=N1)\C(=C1\C=C/C(/N1)=C(/C1=N/C(/CC1)=C2/C1=CC(O)=CC=C1)C1=CC(O)=CC=C1)\C1=CC(O)=CC=C1)C1=CC(O)=CC=C1 LYPFDBRUNKHDGX-SOGSVHMOSA-N 0.000 description 2
- 244000131316 Panax pseudoginseng Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 2
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 2
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000037180 bone health Effects 0.000 description 2
- 210000005056 cell body Anatomy 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 230000001151 other effect Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000001835 salubrious effect Effects 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 229960002197 temoporfin Drugs 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 229920001221 xylan Polymers 0.000 description 2
- 150000004823 xylans Chemical class 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010067162 Asthenospermia Diseases 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 240000008892 Helianthus tuberosus Species 0.000 description 1
- 235000003230 Helianthus tuberosus Nutrition 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 208000005100 Herpetic Keratitis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- 240000006859 Jasminum officinale Species 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 241000366676 Justicia pectoralis Species 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- FLDFNEBHEXLZRX-DLQNOBSRSA-N Nystose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FLDFNEBHEXLZRX-DLQNOBSRSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010073938 Ophthalmic herpes simplex Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229940100228 acetyl coenzyme a Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000675 anti-caries Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 239000012223 aqueous fraction Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 238000009412 basement excavation Methods 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 229940002008 bifidobacterium bifidum Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 239000002034 butanolic fraction Substances 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000005961 cardioprotection Effects 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 201000009151 chronic rhinitis Diseases 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 210000000078 claw Anatomy 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 210000003617 erythrocyte membrane Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 231100000784 hepatotoxin Toxicity 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 150000002584 ketoses Chemical class 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N methyl alcohol Substances OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- FLDFNEBHEXLZRX-UHFFFAOYSA-N nystose Natural products OC1C(O)C(CO)OC1(CO)OCC1(OCC2(OC3C(C(O)C(O)C(CO)O3)O)C(C(O)C(CO)O2)O)C(O)C(O)C(CO)O1 FLDFNEBHEXLZRX-UHFFFAOYSA-N 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- -1 polysaccharide compound Chemical class 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of polygonatum Solomon's seal sugar-tablet and preparation method thereof, it is prepared from by the raw material of following parts by weight：20 parts of xylose, 15 parts of FOS, 14 parts of sealwort, 10 parts of radix polygonati officinalis, 10 parts of the root of kudzu vine, 8 parts of matrimony vine, 0.7 part of magnesium stearate, 0.036 part of Sodium Benzoate, 0.014 part of vanillic aldehyde；The present invention have functions that easily absorption, finished product curative effect substantially, enhancing body immunity, reducing blood lipid, step-down, it is hypoglycemic, make diastole effectively, increase CF, prevent artery sclerosis, overall preparation process is simple is easy to operate, has no toxic side effect.
Description
Technical field
The present invention relates to healthcare field, more particularly to a kind of polygonatum Solomon's seal sugar-tablet and preparation method thereof.
Background technology
Sealwort is a kind of Chinese medicine, containing Siberian solomonseal rhizome polysaccharide, oligosaccharide and some trace elements in its rhizome, is contained in radix polygonati officinalis
Abundant polysaccharide compound, amino acid and multiple nutritional components.Any of the above nutritional ingredient can strengthen the immunity of human body,
Reducing blood lipid, step-down, it is hypoglycemic, make that diastole is strong, increase CF, prevent artery sclerosis and other effects.
Traditional eats, and the composition of sealwort and radix polygonati officinalis is difficult to be absorbed, defect of this patent for prior art, there is provided
One kind have easily absorb, finished product curative effect substantially, enhancing body immunity, reducing blood lipid, step-down, it is hypoglycemic, make diastole it is strong,
Increase CF, the polygonatum Solomon's seal sugar-tablet of artery sclerosis curative effect prevented, while providing its process is simple easy-operating preparation
Method.
Therefore, produce it is a kind of easily absorb, finished product curative effect substantially, enhancing body immunity, reducing blood lipid, step-down, it is hypoglycemic, make
Diastole is strong, increase CF, prevent the easy-operating polygonatum Solomon's seal sugar-tablet of artery sclerosis, process is simple and its preparation
Method, with extensive market prospects.
The content of the invention
In view of the shortcomings of the prior art, the present invention provide it is a kind of easily absorb, finished product curative effect substantially, enhancing body immunity,
Reducing blood lipid, step-down, it is hypoglycemic, make that diastole is strong, increase CF, prevent artery sclerosis, process is simple easy to operate
Polygonatum Solomon's seal sugar-tablet and preparation method thereof, for overcoming many defects of the prior art.
What technology contents of the invention were realized in：A kind of polygonatum Solomon's seal sugar-tablet, it is by the original of following parts by weight
What material was prepared from：20 parts of xylose, 15 parts of FOS, 14 parts of sealwort, 10 parts of radix polygonati officinalis, 10 parts of the root of kudzu vine, 8 parts of matrimony vine, stearic acid
0.7 part of magnesium, 0.036 part of Sodium Benzoate, 0.014 part of vanillic aldehyde.
A kind of preparation method of polygonatum Solomon's seal sugar-tablet as described above, its preparation method is as follows：
1）100 mesh sieves are crossed after the matrimony vine of above-mentioned parts by weight is crushed first, is then packed with aseptic plastic bag；
2）One hour of immersion in container is placed on after the sealwort of above-mentioned parts by weight, radix polygonati officinalis and the root of kudzu vine are cleaned, is fallen after immersion
Enter in steamer, add water, untill water there was not raw material, steamer is heated up, to 100 degrees Celsius of beginning timing, kept for a hour
Stop heating afterwards, filtered after being cooled to room temperature, obtain extracting filtrate；
3）The Sodium Benzoate and vanillic aldehyde of above-mentioned parts by weight are inserted in stainless-steel pan, step 2 is added）In extraction filtrate with
And the drinking water that parts by weight are 8 parts, it is stirred until homogeneous, it is 14 parts to be then slow added into drinking water to overall weight number,
Stir while adding to uniform color position, obtain the adhesive that parts by weight are 14 parts；
4）By above-mentioned steps 1）The xylose of matrimony vine after middle crushing and above-mentioned parts by weight, FOS and magnesium stearate are added
Mix in mixer ten minutes, above-mentioned steps 3 are then added while stirring）In adhesive, mix ten minutes, obtain sticky mixing
Thing；
5）By step 4）In viscous mixture be put into swing comminutor, sieve number is 14 mesh, then start machine, system
Into particle；
6）By step 5）In particle be obtained be put into baking box, temperature is set as 60 degrees Celsius, and drying to pellet moisture is percent
Two to 5 percent；
7）By step 6）Particle after middle baking is pressed into compressing tablet after crossing 14 mesh sieves into tablet press machine, and compressing tablet is fitted into bottle, often
90, bottle, and box is packaged into, per one bottle of box, case being then packaged into, each 240 box obtains finished product, is put in storage after the assay was approved.
The present invention has following good effect：The present invention have easily absorb, finished product curative effect substantially, enhancing human immunity
Power, reducing blood lipid, step-down, it is hypoglycemic, make effect that diastole is strong, increases CF, prevent artery sclerosis, overall system
Standby process is simple is easy to operate, has no toxic side effect.
Xylose is a component of xylan, and xylan is widely present in plant.Xylose exists in animal heparin, soft
In ossein and glycoprotein, it is the connection unit of sugar chain and serine in some glycoprotein.Trip is not found also so far in nature
From the xylose of state.Its effect provides intercellular linking function for the saccharic conjugate of the recipient on cell membrane；Have anti-thin
Bacterium and antifungi function, especially Gram-negative bacteria and streptococcus albus；Help enteral growth of probiotics.
FOS, also known as fructooligosaccharide, is by the fructose base junction in β glycosidic bonds and sucrose by 1 to 3 fructosyl
Symphysis into ketose, Nystose and GF4 etc. mixture.60 to 70 grams of chrysanthemums are there are about in 100 grams of dry weight jerusalem artichokes
Powder.In addition to the physicochemical properties with general utility functions oligosaccharide, most noticeable physiological property is its energy to FOS
Microbial population ratio in enteron aisle is obviously improved, it is the activation and proliferation factor of enteral Bifidobacterium, can reduce and suppress enteral
The generation of corrupt substance, suppresses the growth of harmful bacteria, regulating intestinal canal inner equilibrium；Can promote trace elements iron, the absorption of calcium with
Utilize, to prevent osteoporosis；Hepatotoxin can be reduced, the organic acid of anticancer can be generated in intestines, there is significant anti-cancer work(
Energy；And pure taste is sweet and delicious, with the adipose fragrance of class and tasty and refreshing soapy feeling.The product wind of FOS in recent years
Waste the health-product markets such as day, Europe, the United States.Syrup is colourless or faint yellow, clear viscous liquids, and band FOS delicate fragrance, sweet taste is soft
With salubrious, free from extraneous odour, without exogenous impurity.Icing Sugar is white or slightly yellow unformed powder, and sweet taste is soft salubrious, band FOS
Delicate fragrance, free from extraneous odour, without exogenous impurity.Possess following effects：1. low calorie value, because FOS can not directly be disappeared by human body
Change and absorb, can only be absorbed by enteric bacteria, therefore its calorific value is low, will not cause obesity, also there is antiobesity action indirectly.To glycosuria
It is also a kind of good sweetener for patient.2. because it can not be utilized by oral bacteria, thus make with anti-caries
With.3. the proliferation function of pair enteron aisle beneficial bacteria.FOS has choosing to profitable strain in enteron aisle such as Bifidobacterium Bifidum, Bacillus acidi lactici etc.
Selecting property proliferation function, makes profitable strain be taken advantage in enteron aisle, suppresses the growth of harmful bacteria, reduces the formation of noxious material,
There is protective effect to intestinal mucosa cells and liver, so as to prevent the generation of lesion intestinal cancer, strengthen immunity of organisms.4. can reduce
The content of cholesterol in serum and triglycerides.5. the absorption of nutrition, the especially absorption of calcium are promoted.Intake FOS energy
Absorption of the organism to calcium ion is improved, this phenomenon is of increased attention, and some human clinical trials are also able to
Carry out successively.For teenager, the inulin containing abundant FOS is confirmed can be by strengthening calcium absorption and increasing bone density
Positive effectiveness is produced to bone health.For the women after menopause, the inulin rich in FOS confirms that mineral matter can be improved
Absorb and improve bone health.Separately there are clinical study results to point out, inulin of the supplement containing abundant FOS can be helped improve
The mineral absorption of climacteric women simultaneously influences its bone update mark.6. preventing and treating diarrhoea and constipation.
Sealwort, also known as：Polygonatum sibiricum Redoute, yellow chicken dish, shaft of a writing brush dish, claw ginseng, tendrilleaf solomonseal rhizome, achickenclaw ginseng.It is HUANGJING ZANYU CAPSULE, root
Stem it is horizontal walk, cylindric, tubercle expands.Impeller is given birth to, stockless.Medicinal plant, with tonifying spleen, the effect of moistening lung is promoted the production of body fluid.Its pharmacology is made
With for：1st, resisting pathogenic microbes effect：In vitro test shows, sealwort water extraction goes out liquid（1:320）To typhoid bacillus, golden yellow grape
Coccus, acid-fast bacilli have the yellow Refinement of suppression, and 2% sealwort has different degrees of suppression in sabouraud culture medium to common causative fungi
Make and use.2nd, to the influence of blood sugar：Rabbit gavage huang jing extract, its blood-sugar content increases, then reduces gradually.Huang jing extract is to kidney
The blood sugar that upper parathyrine causes is too high in significant inhibitory action.3rd, antifatigue effect：Sealwort decoction 0.3ml/ abdomen of 17.67% concentration
Chamber is injected, and can extend mouse swimming time.4th, antioxidation：The concentration of sealwort decocting liquid 20%, 13ml/ only feeds and drinks, continuous 27 days,
Make mouse liver superoxide dismutase（SOD）Activity is raised, myocardium lipofuscin content reduction.5th, delaying senility function：Sealwort
Decoction, 20% concentration immersion mulberry leaf feed silkworm, play the role of to extend the silkworm larva phase.6th, anastalsis：Sealwort methanolic extract
Only, only, only, intraperitoneal injection freezes mouse tail 1 to aqueous fraction 20mg/ to n-butanol fraction 20mg/ to 40mg/ to dry ice-methyl alcohol
Minute, the experiment of back-end crop method shows there is anastalsis, reduces mouse amount of bleeding.7th, to Cardiovascular：Sealwort aqueous extract 0.16 ~
0.26g/kg is injected intravenously, hence it is evident that increase anesthetized dog coronary flow；1.5g/kg is injected intravenously, and pituitrin is caused
Rabbit myocardial ischemia has antagonism, and the T ripples that confrontation pituitrin causes increase, and promote T ripples to recover in advance extremely；12g/kg
Intraperitoneal injection, can strengthen tolerance of the mouse to anoxic.8th, antivirus action：The ocular fluid eye drip of Siberian solomonseal rhizome polysaccharide 0.2%, 6 times/day, or
Siberian solomonseal rhizome polysaccharide 10mg/kg is added, 2 times/day, has therapeutic action to the experimental herpes simplex keratitis of rabbit.9th, other
Effect：Sealwort decoction 6g/kg gavages, continuous 10 days, can improve Movse Erythrocyte Membrane Na+, K+ -- atpase activity.40% sealwort
0.3ml/ intraperitoneal injection of alcohol extract, can improve the incorporation efficiency of mouse cardiac muscle, liver, spleen histocyte DNA to 3H ~ TdR.Sealwort is decocted
0.5g/ gavage of agent makes mice plasma cAMP, cGMP content decline, and more with cGMP declines, therefore cAMP/cGMP ratios
More than control group, spleen tissue cAMP, cGMP content is risen, but cAMP/cGMP ratios are without significant change.
There is radix polygonati officinalis hypoglycemic, blood fat, blood pressure etc. to act on.Radix polygonati officinalis tool yin-nourishing, moisturize, heat-clearing, promote the production of body fluid, cough-relieving the effects such as.It is used as
Tonic, cures mainly the diseases such as consumption of YIN caused by febrile disease, abnormal heat cough caused by dryness, heart disease, diabetes, tuberculosis, and can make high-grade nourishing food, good
Meat and fish dishes and beverage, it is with health role.
The root of kudzu vine, is the dry root of legume pueraria lobata, practises and claims elegant jessamine.Autumn, the excavation of season in winter two, take advantage of fresh-cut into sheet or small
Block；Dry.It is sweet, pungent, it is cool.There is expelling pathogenic factors from muscles and skin to bring down a fever, promoting eruption promotes the production of body fluid to quench thirst, the work(of Shengyang Zhixie.It is usually used in table card heating, rigid neck and back
Bitterly, measles without adequate eruption, pyreticosis is thirsty, and the deficiency of Yin is quenched one's thirst, and heat is purged heat dysentery, splenasthenic diarrhea.Demonstrate,proved for table and generated heat, stiff nape and back, measles is not
Thoroughly, pyreticosis is thirsty, and the deficiency of Yin is quenched one's thirst, and heat is purged heat dysentery, splenasthenic diarrhea.
Matrimony vine is the traditional Chinese medicine of China.Liver is synthetic cholesterol and the most place of neutral fat.The fruit of Chinese wolfberry
The materials such as organic germanium can protect liver, suppress fat and hoarded in liver, promote the activation of liver cell, the impaired liver of maintenance
Cell.Research points out that the fruit of Chinese wolfberry can strengthen the phagocytosis of desmacyte, can also promote the growth of Bacillus acidi lactici, while regulation
Immune response, Reduce allergy symptom, to symptoms such as allergic rhinitis, rhinitis chronic, asthma, there is inhibitory action.With removing people
The effect of body free radical, can effective cardioprotection blood vessel endothelium, maintain the elasticity of blood vessel, can also suppress heartbeat, to the adjustment rhythm of the heart
It is uneven also helpful.Vitamin A synthesis is also participated in, the ferro element for containing can promote hematopoiesis function.Additionally, contained vitamin B1,
B2, C and calcium, the health to eyes are beneficial to.The materials such as the LBP-X in matrimony vine, have protective effect to reproductive system, special
It is not the secretion that can promote sex hormone, can treats woman infertility, the disease such as treatment mankind spermatozoon rareness and asthenospermia yet
Shape, proper amount of edible, can tonifying Qi it is strong smart, nourishing liver and kidney.
Magnesium stearate is the white easily fine powder without grittiness；It is micro- to have special smell；Soapy feeling has been contacted with skin.This product water,
It is insoluble in ethanol or ether, it is mainly used as lubricant, antiplastering aid, glidant.The granulation of particularly suitable oils, extract medicament,
The particle being made has good mobility and compressibility.It is used as glidant in direct tablet compressing.It is alternatively arranged as filter aid, clarification
Agent and drip infusion, and liquid preparation suspending agent, thickener.Sodium Benzoate is mostly white particle, and odorless or micro-strip are rested in peace
Fragrance taste, taste is micro- sweet, there is convergence；It is soluble in water（Normal temperature）53.0g/100ml or so, PH are 8 or so；Sodium Benzoate is also acid
Property preservative, without sterilized, bacteriostasis in alkaline medium；The optimal PH of its anti-corrosion is 2.5-4.0,5% solution in PH5.0
Bactericidal effect is nor very well.Sodium Benzoate lipophile is larger, and easy penetration cell film enters in cell body, interference cell film it is logical
Permeability, suppresses absorption of the cell membrane to amino acid；Intracellular alkali storage is acidified into cell body internal ionization, and suppresses exhaling for cell
The activity of enzyme system is inhaled, acetyl coenzyme A condensation reaction is prevented, so as to play the purpose of food antiseptic.Vanillic aldehyde, also known as vanillic aldehyde,
It is a kind of widely used edible spices, can be found in the seed of vanilla, it is also possible to artificial synthesized, there is strong milk fragrance
Breath.It is widely used in the various blending food for needing and increase milk breath, such as cake, cold drink, chocolate, candy；Also can use
In perfumed soap, toothpaste, perfume, rubber, plastics, pharmaceuticals.
Specific embodiment
A kind of polygonatum Solomon's seal sugar-tablet, it is prepared from by the raw material of following parts by weight：20 kilograms of xylose, oligomeric fruit
15 kilograms of sugar, 14 kilograms of sealwort, 10 kilograms of radix polygonati officinalis, 10 kilograms of the root of kudzu vine, 8 kilograms of matrimony vine, 0.7 kilogram of magnesium stearate, Sodium Benzoate
0.036 kilogram, 0.014 kilogram of vanillic aldehyde.
A kind of preparation method of polygonatum Solomon's seal sugar-tablet as described above, its preparation method is as follows：
1）100 mesh sieves are crossed after the matrimony vine of above-mentioned weight is crushed first, is then packed with aseptic plastic bag；
2）One hour of immersion in container is placed on after the sealwort of above-mentioned weight, radix polygonati officinalis and the root of kudzu vine are cleaned, steaming is poured into after immersion
In pot, add water, untill water there was not raw material, steamer is heated up, to 100 degrees Celsius of beginning timing, stop after being kept for a hour
Only heat, filtered after being cooled to room temperature, obtain extracting filtrate；
3）The Sodium Benzoate and vanillic aldehyde of above-mentioned weight are inserted in stainless-steel pan, step 2 is added）In extraction filtrate and 8
Kilogram drinking water, be stirred until homogeneous, be then slow added into drinking water to overall weight be 14 kilograms, stir while adding to
Uniform color position, obtains the adhesive that weight is 14 kilograms；
4）By above-mentioned steps 1）The xylose of matrimony vine after middle crushing and above-mentioned weight, FOS and magnesium stearate are added and mixed
Mix in machine ten minutes, above-mentioned steps 3 are then added while stirring）In adhesive, mix ten minutes, obtain viscous mixture；
5）By step 4）In viscous mixture be put into swing comminutor, sieve number is 14 mesh, then start machine, system
Into particle；
6）By step 5）In particle be obtained be put into baking box, temperature is set as 60 degrees Celsius, and drying to pellet moisture is percent
Two to 5 percent；
7）By step 6）Particle after middle baking is pressed into compressing tablet after crossing 14 mesh sieves into tablet press machine, and compressing tablet is fitted into bottle, often
90, bottle, and box is packaged into, per one bottle of box, case being then packaged into, each 240 box obtains finished product, is put in storage after the assay was approved.
Claims (2)
1. a kind of polygonatum Solomon's seal sugar-tablet, it is characterised in that it is prepared from by the raw material of following parts by weight：Xylose 20
Part, 15 parts of FOS, 14 parts of sealwort, 10 parts of radix polygonati officinalis, 10 parts of the root of kudzu vine, 8 parts of matrimony vine, 0.7 part of magnesium stearate, Sodium Benzoate
0.036 part, 0.014 part of vanillic aldehyde.
2. a kind of preparation method of polygonatum Solomon's seal sugar-tablet as claimed in claim 1, it is characterised in that its preparation method is as follows：
1）100 mesh sieves are crossed after the matrimony vine of above-mentioned parts by weight is crushed first, is then packed with aseptic plastic bag；
2）One hour of immersion in container is placed on after the sealwort of above-mentioned parts by weight, radix polygonati officinalis and the root of kudzu vine are cleaned, is fallen after immersion
Enter in steamer, add water, untill water there was not raw material, steamer is heated up, to 100 degrees Celsius of beginning timing, kept for a hour
Stop heating afterwards, filtered after being cooled to room temperature, obtain extracting filtrate；
3）The Sodium Benzoate and vanillic aldehyde of above-mentioned parts by weight are inserted in stainless-steel pan, step 2 is added）In extraction filtrate with
And the drinking water that parts by weight are 8 parts, it is stirred until homogeneous, it is 14 parts to be then slow added into drinking water to overall weight number,
Stir while adding to uniform color position, obtain the adhesive that parts by weight are 14 parts；
4）By above-mentioned steps 1）The xylose of matrimony vine after middle crushing and above-mentioned parts by weight, FOS and magnesium stearate are added
Mix in mixer ten minutes, above-mentioned steps 3 are then added while stirring）In adhesive, mix ten minutes, obtain sticky mixing
Thing；
5）By step 4）In viscous mixture be put into swing comminutor, sieve number is 14 mesh, then start machine, system
Into particle；
6）By step 5）In particle be obtained be put into baking box, temperature is set as 60 degrees Celsius, and drying to pellet moisture is percent
Two to 5 percent；
7）By step 6）Particle after middle baking is pressed into compressing tablet after crossing 14 mesh sieves into tablet press machine, and compressing tablet is fitted into bottle, often
90, bottle, and box is packaged into, per one bottle of box, case being then packaged into, each 240 box obtains finished product, is put in storage after the assay was approved.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611079468.XA CN106720829A (en) | 2016-11-30 | 2016-11-30 | A kind of polygonatum Solomon's seal sugar-tablet and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611079468.XA CN106720829A (en) | 2016-11-30 | 2016-11-30 | A kind of polygonatum Solomon's seal sugar-tablet and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106720829A true CN106720829A (en) | 2017-05-31 |
Family
ID=58901061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611079468.XA Pending CN106720829A (en) | 2016-11-30 | 2016-11-30 | A kind of polygonatum Solomon's seal sugar-tablet and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106720829A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108271905A (en) * | 2018-02-12 | 2018-07-13 | 广东省测试分析研究所（中国广州分析测试中心） | A kind of ampelopsis grossdentata leaf pressed candy and preparation method thereof |
| CN111544520A (en) * | 2020-06-01 | 2020-08-18 | 辽宁鑫健林国医堂健康管理有限公司 | Preparation method of microbial fermentation tablet candy for warming and invigorating kidney yang |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1973683A (en) * | 2006-12-15 | 2007-06-06 | 张静 | Health food and its production process |
| CN101690777A (en) * | 2009-10-13 | 2010-04-07 | 成永燕 | Formula of polygonatum chewable tablets and preparation method thereof |
| CN103638395A (en) * | 2013-12-19 | 2014-03-19 | 青岛友铭辰生物技术有限公司 | Traditional Chinese medicine tablet for regulating blood sugar and preparation method thereof |
| CN104782869A (en) * | 2015-05-06 | 2015-07-22 | 广禾堂草本生物科技（上海）有限公司 | Sealwort pressed candy and preparation method thereof |
| CN106344655A (en) * | 2016-10-08 | 2017-01-25 | 湖北三峡神农生物科技有限公司 | Traditional Chinese medicinal composition with blood glucose reducing effect and manufacturing method thereof |
-
2016
- 2016-11-30 CN CN201611079468.XA patent/CN106720829A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1973683A (en) * | 2006-12-15 | 2007-06-06 | 张静 | Health food and its production process |
| CN101690777A (en) * | 2009-10-13 | 2010-04-07 | 成永燕 | Formula of polygonatum chewable tablets and preparation method thereof |
| CN103638395A (en) * | 2013-12-19 | 2014-03-19 | 青岛友铭辰生物技术有限公司 | Traditional Chinese medicine tablet for regulating blood sugar and preparation method thereof |
| CN104782869A (en) * | 2015-05-06 | 2015-07-22 | 广禾堂草本生物科技（上海）有限公司 | Sealwort pressed candy and preparation method thereof |
| CN106344655A (en) * | 2016-10-08 | 2017-01-25 | 湖北三峡神农生物科技有限公司 | Traditional Chinese medicinal composition with blood glucose reducing effect and manufacturing method thereof |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108271905A (en) * | 2018-02-12 | 2018-07-13 | 广东省测试分析研究所（中国广州分析测试中心） | A kind of ampelopsis grossdentata leaf pressed candy and preparation method thereof |
| CN111544520A (en) * | 2020-06-01 | 2020-08-18 | 辽宁鑫健林国医堂健康管理有限公司 | Preparation method of microbial fermentation tablet candy for warming and invigorating kidney yang |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103947967B (en) | Double-colored dark red fruit matrimony vine sheet and preparation method thereof | |
| CN102511869B (en) | Thickened red jujube ginger pulp | |
| CN105296584A (en) | Preparation method of marine biological health care peptide preparation | |
| CN101589801B (en) | Process for manufacturing red ginseng honey slice | |
| CN102511861A (en) | Thickened red jujube pulp added with oligosaccharide | |
| CN106615468A (en) | Golden camellia plant beverage for replenishing blood and maintaining beauty | |
| CN102511864B (en) | Jujube high-consistency stock | |
| CN106360213A (en) | Rhizoma polygonati plant beverage and preparation method thereof | |
| CN105533574A (en) | Toxin removing and body slimming green plum fruit and production technology thereof | |
| CN107173656A (en) | A kind of Chinese medicine fruits and vegetables probiotics fermented beverage and preparation method thereof | |
| CN114128813A (en) | Beverage for relieving alcoholism and protecting liver and promoting vitality of liver and preparation method thereof | |
| CN110214816A (en) | A kind of natto polypeptide soymilk powder instant food and preparation method thereof | |
| CN103750464A (en) | Asarum sagittarioides intelligence-improving functional beverage and preparation method thereof | |
| CN102511876B (en) | Hawthorn red jujube thick syrup and production process thereof | |
| CN103055157B (en) | Compound dendrobium huoshanense, cistanche and ganoderma granules and production process thereof | |
| CN106720829A (en) | A kind of polygonatum Solomon's seal sugar-tablet and preparation method thereof | |
| CN105639282B (en) | Expand root health preservation powder and its preparation process in chrysanthemum mountain | |
| CN113925172A (en) | Giant salamander peptide nutritional composition suitable for children | |
| CN102511870A (en) | Thickened red jujube pulp beneficial to losing weight | |
| CN102511882A (en) | Red jujube thick syrup beneficial for improving growth and development | |
| CN102511868A (en) | Thickened red jujube donkey-hide gelatin pulp added with vitamin | |
| CN101530210B (en) | Health preserving wine | |
| CN102511879B (en) | Thickened red jujube guiling jelly pulp | |
| CN102511860B (en) | Thickened red jujube pulp added with phytosterin and being suitable for being taken by pregnant women | |
| CN102599312B (en) | Oligosaccharide Panax notoginseng sweet tea and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170531 |